Related Experiment Video
Updated: Aug 9, 2025

Intravitreal Injection and Quantitation of Infection Parameters in a Mouse Model of Bacterial Endophthalmitis
Published on: February 6, 2021
Outcomes and Clinical Features Predictive of Fungal Endophthalmitis
Aaron Z Priluck1, Peng Huang2, Mark P Breazzano3
1From the Wilmer Eye Institute, Johns Hopkins Hospital; Johns Hopkins University School of Medicine (A.Z.P., M.P.B.), Baltimore, Maryland.
Purpose:
To analyze intravitreal antifungal injections performed at a tertiary center to determine (1) risk factors increasing fungal endophthalmitis likelihood at the time of patient presentation, (2) prognostic factors at presentation, and (3) validity of American Academy of Ophthalmology (Academy) ophthalmologic Candida septicemia (candidemia) screening guidelines.
Design:
Single-center, retrospective clinical case-control study.
Methods:
Clinical course, visual outcome, and final diagnosis were analyzed for 75 patients (81 eyes) receiving intravitreal antifungal injections between 2014 and 2021. Features were compared between fungal endophthalmitis and clinically similar diseases (masquerades).
Results:
Fungal endophthalmitis was more likely than masquerade based on injection in emergency department or inpatient setting (P = .0002) vs outpatient, greater visual acuity (P = .049), artificial indwelling line present (P = .0004), sepsis within past 6 months (P = .0002), prior/current hepatitis C diagnosis (P = .044), total parenteral nutrition (P = .0028), complicated diabetes mellitus (P = .035), actively treated cancer (P = .021), immunosuppressive medication within past year (P = .035), immunocompromising condition number (P = .031), and delayed pain (P = .0094) and vision loss (P = .020) onset. Visual acuity at presentation correlated with visual outcome (R2 = 0.3524, P = 8.5 × 10-7). No patients with fungal endophthalmitis were asymptomatic or identified by screening.
Conclusions:
Many conditions can mimic fungal endophthalmitis, but certain risk factors should raise its suspicion. Regardless of diagnosis, presenting vision correlates with final vision. Lastly, no patients with fungal endophthalmitis were asymptomatic or identified by screening, further supporting current Academy candidemia screening guidelines.
Insights
Certain risk factors increase fungal endophthalmitis likelihood after intravitreal antifungal injections. Presenting visual acuity is a key prognostic factor, and current screening guidelines appear valid as no fungal endophthalmitis cases were asymptomatic.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Medical Research
Background:
- Intravitreal antifungal injections are used to treat fungal eye infections.
- Distinguishing fungal endophthalmitis from similar conditions is crucial for appropriate management.
- Risk factors and prognostic indicators for fungal endophthalmitis require further elucidation.
Purpose of the Study:
- To identify risk factors associated with fungal endophthalmitis at presentation.
- To determine prognostic factors influencing visual outcomes in patients receiving intravitreal antifungal injections.
- To evaluate the effectiveness of American Academy of Ophthalmology (Academy) screening guidelines for Candida septicemia (candidemia).
Main Methods:
- A retrospective case-control study was conducted at a single tertiary center.
- Data from 75 patients (81 eyes) treated with intravitreal antifungal injections between 2014 and 2021 were analyzed.
- Clinical features, visual outcomes, and final diagnoses were compared between fungal endophthalmitis and masquerade syndromes.
Main Results:
- Factors significantly increasing fungal endophthalmitis likelihood included emergency department/inpatient injection, presence of an artificial indwelling line, recent sepsis, and specific comorbidities like complicated diabetes mellitus and actively treated cancer.
- Presenting visual acuity was a strong predictor of final visual outcome (R² = 0.3524, P < .0001).
- No patients diagnosed with fungal endophthalmitis were asymptomatic or identified through screening protocols.
Conclusions:
- Specific patient and treatment-related factors can indicate a higher risk of fungal endophthalmitis.
- Presenting visual acuity is a critical prognostic factor for visual recovery.
- The findings support the current Academy candidemia screening guidelines, as no fungal endophthalmitis cases were detected via screening.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Fungal Phylum Microsporidia
Myocarditis II: Clinical Features and Diagnostic Tests
Glaucoma: Overview
Endocarditis IV: Nursing Management
Endocarditis III: Medical Management

